Armando Bartolazzi

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: THYROID. 2020;30(9):1314-1326
Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive In Vivo Imaging of Thyroid Cancer
Peplau E; De Rose F; Reder S; Mittelhaeuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; Skerra A; D'Alessandria C
Article: JOURNAL OF NUCLEAR MEDICINE. 2019;60(6):770-776
Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer
De Rose F; Braeuer M; Braesch-Andersen S; Otto AM; Steiger K; Reder S; Mall S; Nekolla S; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C
Article: EUROPEAN JOURNAL OF CANCER PREVENTION. 2019;28(3):203-211
25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies
Cattaruzza MS; Pisani D; Fidanza L; Gandini S; Marmo G; Narcisi A; Bartolazzi A; Carlesimo M
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2019;20(7):E1607-1607
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs
Capalbo C; Scafetta G; Filetti M; Marchetti P; Bartolazzi A
Article: DERMATOLOGIC THERAPY. 2019;32(1):e12764
A "seasonal bromoderma" in a farmer
Pranteda G; Magri F; Muscianese M; D'Arino A; Pranteda G; Fidanza L; Bartolazzi A
Journal article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2018;19(10):E2934-2934
Galectins in Cancer and Translational Medicine: From Bench to Bedside
Bartolazzi A
Article: METABOLISM: CLINICAL AND EXPERIMENTAL. 2018;83:149-158
Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice
Iacobini C; Fantauzzi CB; Bedini R; Pecci R; Bartolazzi A; Amadio B; Pesce C; Pugliese G; Menini S
Article: ONCOTARGET. 2017;8(30):49421-49442
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology
Sciacchitano S; Lavra L; Ulivieri A; Magi F; De Francesco GP; Bellotti C; Salehi LB; Trovato M; Drago C; Bartolazzi A
Article: SCIENTIFIC REPORTS. 2017;7:40370
Antiproliferative Effects of 1α-OH-vitD₃ in Malignant Melanoma: Potential Therapeutic implications
Spath L; Ulivieri A; Lavra L; Fidanza L; Carlesimo M; Giubettini M; Narcisi A; Luciani E; Bucci B; Pisani D; Sciacchitano S; Bartolazzi A
Article: ENDOCRINE. 2016;54(1):139-147
Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules
Sciacchitano S; Lavra L; Ulivieri A; Magi F; Porcelli T; Amendola S; De Francesco GP; Bellotti C; Trovato MC; Salehi LB; Bartolazzi A
Article: CANCER RESEARCH. 2016;76(12):3583-3592
Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3
D'Alessandria C; Braesch-Andersen S; Bejo K; Reder S; Blechert B; Schwaiger M; Bartolazzi A
Article: SCIENTIFIC REPORTS. 2015;5:13246
Investigation of VOCs associated with different characteristics of breast cancer cells
Lavra L; Catini A; Ulivieri A; Capuano R; Salehi LB; Sciacchitano S; Bartolazzi A; Nardis S; Paolesse R; Martinelli E; Di Natale C
Article: INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2015;23(5):419-423
Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Warthin Tumor of the Parotid Gland: A Case Report and Literature Review
Di Napoli A; Mallel G; Bartolazzi A; Cavalieri E; Becelli R; Cippitelli C; Ruco L
Article: ONCOTARGET. 2015;6(12):10320-10334
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity
Valente D; Bossi G; Moncada A; Tornincasa M; Indelicato S; Piscuoglio S; Karamitopoulou ED; Bartolazzi A; Pierantoni GM; Fusco A; Soddu S; Rinaldo C
Article: INTERNATIONAL JOURNAL OF CANCER. 2014;134(8):1823-1834
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells
Paroli M; Bellati F; Videtta M; Focaccetti C; Mancone C; Donato T; Antonilli M; Perniola G; Accapezzato D; Napoletano C; Nuti M; Bartolazzi A; Panici PB; Tripodi M; Palombo F; Barnaba V
Article: CELL DEATH AND DISEASE. 2014;5(3):e1100
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors
Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
Article: AMERICAN SURGEON. 2013;79(12):E351-E353
Primary Thyroid Paraganglioma: A Rare Entity Affecting Middle-aged Women
D'Angelo FA; Antolino L; Magistri P; Giubettini M; Aurello P; Maceli F; Bollanti L; Bartolazzi A; Ramacciato G
Article: CASE REPORTS IN RHEUMATOLOGY. 2013;2013:857694-4
A case of subacute cutaneous lupus erythematosus in a patient with mixed connective tissue disease: successful treatment with plasmapheresis and rituximab.
Fantò M; Salemi S; Socciarelli F; Bartolazzi A; Natale GA; Casorelli I; Pavan A; Vaglio S; Di Rosa R; D'Amelio R
Article: JOURNAL OF CELLULAR PHYSIOLOGY. 2013;228(1):235-241
Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis
Ricci A; Cherubini E; Ulivieri A; Lavra L; Sciacchitano S; Scozzi D; Mancini R; Ciliberto G; Bartolazzi A; Bruno P; Graziano P; Mariotta S
Article: CUTIS. 2012;90(4):196-199
Renal Cell Carcinoma Diagnosed by Cutaneous Metastasis: A Case Report
Carlesimo M; Abruzzese C; Narcisi A; Arcese A; Cortesi G; Di Russo PP; Fidanza L; Feliziani G; Gargano C; Bartoiri A; Camplone G
Article: MOLECULAR CELL. 2012;47(1):87-98
HIPK2 Controls Cytokinesis and Prevents Tetraploidization by Phosphorylating Histone H2B at the Midbody
Rinaldo C; Moncada A; Gradi A; Ciuffini L; D'Eliseo D; Siepi F; Prodosmo A; Giorgi A; Pierantoni GM; Trapasso F; Guarguaglini G; Bartolazzi A; Cundari E; Schinina ME; Fusco A; Soddu S
Article: PLOS ONE. 2012;7(11):e49139
Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells
Veschi V; Petroni M; Cardinali B; Dominici C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Giannini G
Article: ONCOGENE. 2011;30(48):4802-4813
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage
Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
Article: AMERICAN JOURNAL OF EMERGENCY MEDICINE. 2011;29(6):694.e3-694.e6
Hyperbaric oxygen therapy in a case of cholesterol crystal embolization
Gurgo A; Valenti V; Paneni F; Passerini J; Di Vavo M; Calvieri C; Cacchi C; Bartolazzi A; Sabani A; Volpe M
Article: MOLECULAR CANCER RESEARCH. 2011;9(1):67-77
MYCN Sensitizes Human Neuroblastoma to Apoptosis by HIPK2 Activation through a DNA Damage Response
Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
Article: PLOS ONE. 2011;6(6):e20665
The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas
Lavra L; Rinaldo C; Ulivieri A; Luciani E; Fidanza P; Giacomelli L; Bellotti C; Ricci A; Trovato M; Soddu S; Bartolazzi A; Sciacchitano S
Article: SENSORS AND ACTUATORS, B: CHEMICAL. 2010;146(2):483-488
A sensor array and GC study about VOCs and cancer cells
Bartolazzi A; Santonico M; Pennazza G; Martinelli E; Paolesse R; D'Amico A; Di Natale C
Article: ANNALS OF MEDICINE. 2010;42(1):70-78
Galectin-3 detection on large-needle aspiration biopsy improves preoperative selection of thyroid nodules: A prospective cohort study
Carpi A; Rossi G; Di Coscio G; Iervasi G; Nicolini A; Carpi F; Mechanick JI; Bartolazzi A
Article: CELL PROLIFERATION. 2009;42(3):373-384
HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage
Iacovelli S; Ciuffni L; Lazzari C; Bracaglia G; Rinaldo C; Prodosmo A; Bartolazzi A; Sacchi A; Soddu S
Article: JOURNAL OF PATHOLOGY. 2009;218(1):66-75
Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas
Lavra L; Ulivieri A; Rinaldo C; Dominici R; Volante M; Luciani E; Bartolazzi A; Frasca F; Soddu S; Sciacchitano S
Article: ACTA OPHTHALMOLOGICA. 2008;46:20-25
Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma. Intercorrelation and prognostic implications
Economou MA; Ericsson CA; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Article: THE LANCET ONCOLOGY. 2008;9(6):543-549
Galectin-3-expression analyses in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscana V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R
Article: JOURNAL OF PATHOLOGY. 2008;215(1):87-96
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
Article: PLOS ONE. 2008;3(11):e3768
Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3
Bartolazzi A; D'Alessandria C; Parisella MG; Signore A; Del Prete F; Lavra L; Braesch-Andersen S; Massari R; Trotta C; Soluri A; Sciacchitano S; Scopinaro F
Article: BRITISH JOURNAL OF CANCER. 2006;95(2):204-209
Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology
Carpi A; Naccarato AG; Iervasi G; Nicolini A; Bevilacqua G; Viacava P; Collecchi P; Lavra L; Marchetti C; Sciacchitano S; Bartolazzi A
Article: MOLECULAR AND CELLULAR BIOLOGY. 2006;26(12):4746-4757
Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis
Cecchinelli B; Lavra L; Rinaldo C; Iacovelli S; Gurtner A; Gasbarri A; Ulivieri A; Del Prete F; Trovato M; Piaggio G; Bartolazzi A; Soddu S; Sciacchitano S
Article: INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE. 2005;46(12):4372-4375
Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: Intercorrelation and prognostic implications
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Article: JOURNAL OF CRANIOFACIAL SURGERY. 2005;16(5):861-864
The rare condition of maxillary osteomyelitis
Indrizzi E; Terenzi V; Renzi G; Bonamini M; Bartolazzi A; Fini G
Article: MODERN PATHOLOGY. 2005;18(4):541-546
Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential
Papotti M; Rodriguez J; De Pompa R; Bartolazzi A; Rosai J
Article: BRITISH JOURNAL OF CANCER. 2004;91(6):1096-1104
Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis
Gasbarri A; Sciacchitano S; Marasco A; Papotti M; Di Napoli A; Marzullo A; Yushkov P; Ruco L; Bartolazzi A
Article: VIRCHOWS ARCHIV. 2004;445(2):183-188
Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid
Volante M; Bozzalla-Cassione F; DePompa R; Saggiorato E; Bartolazzi A; Orlandi F; Papotti M
Article: BIOMEDICINE & PHARMACOTHERAPY. 2004;58(6-7):356-359
From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules
Gasbarri A; Marchetti C; Iervasi G; Bottoni A; Andrea NC; Nicolini A; Bartolazzi A; Carpi A
Article: CANCER RESEARCH. 2004;64(1):236-242
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
Girnita A; Girnita L; del Prete F; Bartolazzi A; Larsson O; Axelson M
Article: MELANOMA RESEARCH. 2003;13(4):325-337
CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage
Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
Article: CANCER RESEARCH. 2002;62(13):3861-3867
SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: A gain of function of the t(X;18)(p11.2;q11.2) translocation
Xie YT; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
Article: MODERN PATHOLOGY. 2002;15(6):679-685
A novel type of SYT/SSX fusion:: Methodological and biological implications
Törnkvist M; Brodin B; Bartolazzi A; Larsson O
Article: JOURNAL OF EXPERIMENTAL MEDICINE (JEM). 2002;195(7):825-834
Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection
Sjölin H; Tomasello E; Mousavi-Jazi M; Bartolazzi A; Kärre K; Vivier E; Cerboni C
Article: INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE. 2002;43(1):1-8
Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Article: INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE. 2001;42(10):2153-2156
Association of HLA class I and class II antigen expression and mortality in uveal melanoma
Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
Article: JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION. 2001;219(1):60-49
Extraskeletal osteosarcoma in a cat
Spugnini EP; Ruslander D; Bartolazzi A
Article: THE LANCET. 2001;357(9269):1644-1650
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
Bartolazzi A; Gasbarri A; Papotti M; Bussolati G; Lucante T; Khan A; Inohara H; Marandino F; Orlandi F; Nardi F; Vecchione A; Tecce R; Larsson O
Article: GENE. 2001;268(1-2):173-182
Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression
Brodin B; Haslam K; Yang K; Bartolazzi A; Xie YT; Starborg M; Lundeberg J; Larsson O
Article: NEUROLOGICAL SCIENCES. 2000;21(4):241-245
Brachial plexus neuropathy as unusual onset of diffuse neurolymphomatosis
Pietrangeli A; Milella M; De Marco S; Bartolazzi A; Mottolese M; Zompetta C; Jandolo B
Article: CANCER RESEARCH. 2000;60(18):5278-5283
Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: Functional impact
Girnita L; Girnita A; Brodin B; Xie YT; Nilsson G; Dricu A; Lundeberg J; Wejde J; Bartolazzi A; Wiman KG; Larsson O
Article: JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION. 2000;36(3):253-256
Seminoma with cutaneous metastases in a dog
Spugnini EP; Bartolazzi A; Ruslander D
Article: JOURNAL OF ORAL PATHOLOGY & MEDICINE. 2000;29(4):173-179
Overexpression of p53 and bcl-2 proteins and the presence of HPV infection are independent events in head and neck cancer
Badaracco G; Venuti A; Bartolazzi A; Morello R; Marzetti F; Marcante ML
Article: JOURNAL OF CLINICAL ONCOLOGY. 1999;17(11):3494-3502
Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules
Gasbarri A; Martegani MP; Del Prete F; Lucante T; Natali PG; Bartolazzi A
Article: AMERICAN JOURNAL OF PATHOLOGY. 1999;154(1):291-300
Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products
Martegani MP; Del Prete F; Gasbarri A; Natali PG; Bartolazzi A
Article: PATHOLOGY RESEARCH AND PRACTICE. 1999;195(1):39-44
Angiomyofibroblastoma and aggressive angiomyxoma: Two benign mesenchymal neoplasms of the female genital tract. An immunohistochemical study
Bigotti G; Coli A; Gasbarri A
Article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 1998;17(1):65-70
Malignant oncocytoma of major salivary glands. Report of a post-irradiation case
Coli A; Bigotti G; Bartolazzi A
Article: JOURNAL OF CELL BIOLOGY. 1996;132(6):1199-1208
Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Bartolazzi A; Nocks A; Aruffo A; Spring F; Stamenkovic I
Article: JOURNAL OF CELL BIOLOGY. 1995;131(6):1623-1633
REGULATION OF CD44 BINDING TO HYALURONAN BY GLYCOSYLATION OF VARIABLY SPLICED EXONS
BENNETT KL; MODRELL B; GREENFIELD B; BARTOLAZZI A; STAMENKOVIC I; PEACH R; JACKSON DG; SPRING F; ARUFFO A
Article: ANTICANCER RESEARCH. 1995;15(5B):2129-2136
Cytogenetic, molecular and phenotypic characterization of the newly established renal carcinoma cell line KJ29. Evidence of translocations for chromosomes 1 and 3
Barletta C; Bartolazzi A; Reale GC; Gambari R; Nastruzzi C; Barbieri R; DelSenno L; Castagnoli A; Natali PG
Article: INTERNATIONAL JOURNAL OF CANCER. 1995;64(4):248-252
EXPRESSION OF ALPHA(3)BETA(1) INTEGRIN RECEPTOR AND ITS LIGANDS IN HUMAN LUNG-TUMORS
BARTOLAZZI A; CERBONI C; FLAMINI G; BIGOTTI A; LAURIOLA L; NATALI PG
Article: JOURNAL OF CELL SCIENCE. 1995;108:1723-1733
REGULATION OF GROWTH ACID DISSEMINATION OF A HUMAN LYMPHOMA BY CD44 SPLICE VARIANTS
BARTOLAZZI A; JACKSON D; BENNETT K; ARUFFO A; DICKINSON R; SHIELDS J; WHITTLE N; STAMENKOVIC I
Visa fler

Alla övriga publikationer

Review: DERMATOLOGIC THERAPY. 2018;31(6):e12725
The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature
Pranteda G; Magri F; Muscianese M; Pigliacelli F; D'Arino A; Federico A; Pranteda G; Bartolazzi A
Letter: DIGESTIVE DISEASES AND SCIENCES. 2013;58(8):2423-2424
Debating the Presentation, Morphology, Origin, and Prognosis of a Combined Hepatocellular-Cholangiocarcinoma
Lorenzon L; Castaldo P; Bartolazzi A; Del Monte SR; Camboni A; Pilozzi E; Salvi P; Ziparo V
Review: APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY. 2012;20(1):2-7
Methodology and Technical Requirements of the Galectin-3 Test for the Preoperative Characterization of Thyroid Nodules
Bartolazzi A; Bellotti C; Sciacchitano S
Letter: EUROPEAN JOURNAL OF CANCER PREVENTION. 2011;20(5):429-430
Efficacy of acitretin in the treatment of squamous cell carcinoma of the oral cavity
Carlesimo M; Narcisi A; Abruzzese C; Orsini D; Cortesi G; Arcese A; Bartolazzi A; Camplone G
Published conference paper: SENSORS AND ACTUATORS, B: CHEMICAL. 2011;154(2):288-294
Monitoring of melanoma released volatile compounds by a gas sensors array: From in vitro to in vivo experiments
Pennazza G; Santonico M; Martinelli E; Paolesse R; Tamburrelli V; Cristina S; D'Amico A; Di Natale C; Bartolazzi A
Letter: AMERICAN SURGEON. 2009;75(3):269-272
Rectal and Gynecologic Amputation for a Giant Eccrine Porocarcinoma of the Pelvic Floor
Salvi PF; Santanelli F; Ferri M; Dente M; Paolini G; Bartolazzi A; Iannicelli E; Ziparo V
Meeting abstract: BIOMEDICINE & PHARMACOTHERAPY. 2008;62(8):520-521
Galectin-3 immunodetection on large needle aspiration biopsy of thyroid nodules
Carpi A; Mechanick J; Nicolini A; Bartolazzi A
Letter: EUROPEAN JOURNAL OF DERMATOLOGY. 2008;18(5):598-600
Actinic Reticulosis with clonal TCR (T-cell receptor) gene rearrangement
Melotti F; Mari E; Giorgiana F; Fidanza L; Carlesimo M; Pilozzi E; Raffa E; Camplone G; Bartolazzi A
Letter: EUROPEAN JOURNAL OF DERMATOLOGY. 2008;18(2):203-204
Angiomatoid lesions revealing an atrial myxoma
Carlesimo M; Mari E; Caperchi C; La Pietra M; Pranteda G; Bartolazzi A; Camplone G
Letter: JOURNAL OF AMERICAN ACADEMY OF DERMATOLOGY. 2007;57(5):S122-S123
Melanoma mimicry on a tattoo: An autograft hypothesis
Persechino S; Caperchi C; Bartolazzi A
Meeting abstract: BIOMEDICINE & PHARMACOTHERAPY. 2006;60(8):491
Analysis of the role of p53 and Galectin-3 in proliferation and apoptosis of thyroid carcinoma cell lines by specific RNA interference experiments
Lavra L; Ulivieri A; Dominici R; Trovato M; Bartolazzi A; Soddu S; Sciacchitano S
Meeting abstract: BIOMEDICINE & PHARMACOTHERAPY. 2006;60(8):492-493
Galectin-3 detection on large needle aspiration biopsy of thyroid nodules: retrospective and prospective studies
Carpi A; Di Coscio G; Iervasi G; Nicolini A; Mantuano E; Bartolazzi A
Letter: HISTOPATHOLOGY. 2006;48(2):212-213
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms
Bartolazzi A; Bussolati G
Meeting abstract: BIOMEDICINE & PHARMACOTHERAPY. 2004;58(8):475
Molecular and functional aspects of Galectin-3 expression in thyroid cancer
Bartolazzi A; Soddu S; Sciacchitano S
Letter: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2003;88(2):950
Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules
Bartolazzi A; Papotti M; Orlandi F
Review: PATHOLOGICA. 2002;94(5):257-262
[Molecular diagnosis of synovial sarcoma].
Martegani MP; Gasbarri A; Bartolazzi A; Ruco L
Letter: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2001;93(17):1348-1349
Re:: A novel fusion gene, SYT-SSX4, in synovial sarcoma -: Responce
Brodin B; Törnkvist M; Haslam K; Xie Y; Bartolazzi A; Larsson O
Letter: THE LANCET. 2000;356(9246):2010-2011
Thyroid disease classification
Bartolazzi A; Gasbarri A
Editorial comment: THE LANCET. 2000;355(9216):1661-1662
Improving accuracy of cytology for nodular thyroid lesions
Bartolazzi A

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI